Humankind Investments LLC Has $293,000 Stock Position in MetLife, Inc. (NYSE:MET)

Humankind Investments LLC lessened its position in shares of MetLife, Inc. (NYSE:MET) by 8.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,575 shares of the financial services provider’s stock after selling 328 shares during the quarter. Humankind Investments LLC’s holdings in MetLife were worth $293,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. CX Institutional boosted its stake in shares of MetLife by 15.9% in the 4th quarter. CX Institutional now owns 68,005 shares of the financial services provider’s stock valued at $5,568,000 after purchasing an additional 9,337 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in MetLife by 109.2% in the fourth quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock valued at $722,727,000 after acquiring an additional 4,606,748 shares during the last quarter. Smartleaf Asset Management LLC grew its holdings in MetLife by 27.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 13,692 shares of the financial services provider’s stock worth $1,116,000 after acquiring an additional 2,940 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of MetLife by 1.7% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 776,244 shares of the financial services provider’s stock valued at $63,559,000 after acquiring an additional 12,723 shares during the last quarter. Finally, Kingswood Wealth Advisors LLC bought a new position in shares of MetLife in the 4th quarter worth $259,000. Institutional investors own 94.99% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. JPMorgan Chase & Co. dropped their price objective on MetLife from $88.00 to $86.00 and set an “overweight” rating for the company in a report on Wednesday, April 2nd. Piper Sandler increased their price target on shares of MetLife from $92.00 to $94.00 and gave the company an “overweight” rating in a research report on Wednesday, April 2nd. Keefe, Bruyette & Woods decreased their price objective on shares of MetLife from $98.00 to $95.00 and set an “outperform” rating for the company in a report on Wednesday, April 9th. UBS Group lifted their price target on shares of MetLife from $94.00 to $98.00 and gave the stock a “buy” rating in a research report on Wednesday, April 2nd. Finally, Cowen restated a “buy” rating on shares of MetLife in a research report on Friday, March 7th. One research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $92.69.

MetLife Stock Up 0.3 %

Shares of MET stock opened at $77.82 on Friday. The firm’s fifty day moving average price is $77.09 and its two-hundred day moving average price is $81.22. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a 1 year low of $65.21 and a 1 year high of $89.05. The firm has a market capitalization of $52.24 billion, a P/E ratio of 13.04, a PEG ratio of 0.65 and a beta of 0.85.

MetLife (NYSE:MET) last issued its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $1.96 EPS for the quarter, missing the consensus estimate of $2.00 by ($0.04). The company had revenue of $18.57 billion for the quarter, compared to analyst estimates of $18.06 billion. MetLife had a net margin of 6.19% and a return on equity of 20.42%. The business’s revenue for the quarter was up 15.6% on a year-over-year basis. During the same period last year, the company posted $1.83 earnings per share. On average, equities analysts predict that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 10th. Investors of record on Tuesday, May 6th will be issued a dividend of $0.5675 per share. This represents a $2.27 dividend on an annualized basis and a yield of 2.92%. This is an increase from MetLife’s previous quarterly dividend of $0.55. The ex-dividend date is Tuesday, May 6th. MetLife’s payout ratio is presently 36.91%.

MetLife declared that its Board of Directors has approved a share repurchase plan on Wednesday, April 30th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to buy up to 5.9% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board of directors believes its stock is undervalued.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.